13.08.2021 H&R GmbH & Co. KGaA  DE000A2E4T77

DGAP-News: H&R GmbH & Co. KGaA confirms good figures for first half-year of 2021


 

DGAP-News: H&R GmbH & Co. KGaA / Key word(s): Half Year Report/Half Year Results
H&R GmbH & Co. KGaA confirms good figures for first half-year of 2021

13.08.2021 / 11:10
The issuer is solely responsible for the content of this announcement.


Press Release

H&R GmbH & Co. KGaA confirms figures for first half-year of 2021

- Operating result (EBITDA) with € 74.4 million significantly better than previous year

- Catch-up effects continue throughout the first half of 2021

- H&R is heading for a very good full-year result

Salzbergen, Germany, August 13, 2021. H&R GmbH & Co. KGaA (short: H&R KGaA; ISIN DE000A2E4T77) achieved an operating group result (EBITDA *) of EUR 74.4 million at the end of the first half of 2021 (1st half of 2020: EUR 16.6 million). With almost identical depreciation, EBIT amounted to EUR 49.1 million (1st half of 2020: EUR -8.7 million). The shareholders' group result closed at EUR 31.0 million (1st half of 2020: EUR -13.6 million). H&R KGaA thus generated earnings per share of EUR 0.83. Due to the price of raw materials, sales increased in the first half of 2021 and reached revenues of EUR 558.4 million (1st half of 2020: EUR 441.8 million).

Overview of main key figures:

in million EUR HY1-2021 HY1-2020 Diff. abs.
Sales revenues 558.4 441.8 116.6
ChemPharm REFINING 352.0 276.9 75.1
ChemPharm SALES 190.7 150.9 39.8
PLASTICS 21.5 18.2 3.3
Consolidation -5.8 -4.2 -1.6
       
Operating result (EBITDA*) 74.4 16.6 57.8
ChemPharm REFINING 58.9 7.0 51.9
ChemPharm SALES 15.2 11.4 3.8
Plastics 1.8 -0.1 1.9
Consolidation -1.5 -1.7 0.2
       
EBIT 49.1 -8.7 57.8
Earnings before taxes 44.5 -12.7 57.2
Net earnings attributable to shareholders 31.0 -13.6 44.6
Earnings per share (in EUR) 0.83 -0.37 1,.0
Operating cash flow 1.1 39.4 -38.3
Free cash flow -24.4 13.6 -38.0
       
  Q2-2021 Q2-2020 Diff. abs.
Sales revenues 317.1 182.4 134.7
ChemPharm REFINING 207.4 106.2 101.2
ChemPharm SALES 102.8 70.7 32.1
PLASTICS 10.6 7.2 3.4
Consolidation -3.7 -1.7 -2.0
       
Operating result (EBITDA) 48.7 5.9 42.8
ChemPharm REFINING 41.4 2.0 39.4
ChemPharm SALES 7.6 4.7 2.9
PLASTICS 0.9 0.0 0.9
Consolidation -1.2 -0.8 -0.4
       
EBIT 36.0 -6.7 42.7
Earnings before taxes 33.2 -9.0 42.2
Net earnings attributable to shareholders 23.7 -8.9 32.6
Earnings per share (in EUR) 0.64 -0.24 0.88
Operating cash flow 5.1 36.5 -31.4
Free cash flow -12.2 35.8 -48.0
       
  30/06/2021 31/12/2020 Diff. abs.
Balance sheet total 855.6 745.7 109.9
Equity 385.0 346.9 38.1
Equity ratio (in %, difference in percentage points) 45.0 46.5 -1.5
 

For the year as a whole, H&R is currently assuming that it will be able to achieve an operating result of at least EUR 115.0 million.

For detailed statements on current and future business and earnings development, the company refers to the semi-annual report as of June 30, 2021 published today, which can be downloaded from H&R KGaA in the "Publications" area at www.hur.com.

* Consolidated income before tax, other financial income and expenses and depreciation/amortization, impairment and appreciation of fixed assets and property, plant and equipment

Contact information:
H&R GmbH & Co. KGaA, Head of Investor Relations/Communications, Ties Kaiser
Neuenkirchener Strasse 8, 48499 Salzbergen
Phone.: +49 40 43218-321, Fax: +49 40 43218-390
Email: [email protected] ; www.hur.com

H&R GmbH & Co. KGaA:
H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil-based chemical and pharmaceutical specialty products and produces high-precision plastic parts.

Forward-looking statements and forecasts:
This press release contains forward-looking statements. The statements are based on the current estimates and forecasts by the Executive Board and the information available to the Board at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this press release.



13.08.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: H&R GmbH & Co. KGaA
Neuenkirchener Str. 8
48499 Salzbergen
Germany
Phone: +49 (0)40 43 218 321
Fax: +49 (0)40 43 218 390
E-mail: [email protected]
Internet: www.hur.com
ISIN: DE000A2E4T77
WKN: A2E4T7
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1226346

 
End of News DGAP News Service

1226346  13.08.2021 

fncls.ssp?fn=show_t_gif&application_id=1226346&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2015 2016 2017 2018 2019 2020 2021e
Umsatzerlöse1 982,91 942,65 1.025,11 1.114,15 1.075,32 873,03 1.150,00
EBITDA1,2 86,00 101,40 97,39 74,70 52,90 55,72 126,50
EBITDA-Marge3 8,75 10,76 9,50 6,70 4,92 6,38 11,00
EBIT1,4 48,89 54,16 54,29 40,17 7,40 -0,35 72,00
EBIT-Marge5 4,97 5,75 5,30 3,61 0,69 -0,04 6,26
Jahresüberschuss1 27,26 39,29 29,50 22,32 0,08 -7,83 40,00
Netto-Marge6 2,77 4,17 2,88 2,00 0,01 -0,90 3,48
Cashflow1,7 56,43 75,45 46,19 23,32 95,86 60,15 95,00
Ergebnis je Aktie8 0,77 1,07 0,88 0,59 -0,04 -0,24 1,05
Dividende8 0,00 0,00 0,40 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Warth & Klein Grant Thornton

INVESTOR-INFORMATIONEN
©boersengefluester.de
H&R
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2E4T7 6,880 Kaufen 256,09
KGV 2022e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
7,64 11,89 0,64 29,78
KBV KCV KUV EV/EBITDA
0,71 4,26 0,22 3,45
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
0,00 0,00 0,00 09.07.2021
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
14.05.2021 13.08.2021 12.11.2021 07.04.2022
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-20,85% -14,10% 25,78% 29,32%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu H&R GmbH & Co. KGaA  ISIN: DE000A2E4T77 können Sie bei DGAP abrufen

Chemie , A2E4T7 , 2HRA , XETR:2HRA